These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35526005)

  • 1. Operational complexity versus design efficiency: challenges of implementing a phase IIa multiple parallel cohort targeted treatment platform trial in advanced breast cancer.
    Snowdon C; Kernaghan S; Moretti L; Turner NC; Ring A; Wilkinson K; Martin S; Foster S; Kilburn LS; Bliss JM
    Trials; 2022 May; 23(1):372. PubMed ID: 35526005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing platforms without stopping the train: experiences of data management and data management systems when adapting platform protocols by adding and closing comparisons.
    Hague D; Townsend S; Masters L; Rauchenberger M; Van Looy N; Diaz-Montana C; Gannon M; James N; Maughan T; Parmar MKB; Brown L; Sydes MR;
    Trials; 2019 May; 20(1):294. PubMed ID: 31138292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Undertaking Studies Within A Trial to evaluate recruitment and retention strategies for randomised controlled trials: lessons learnt from the PROMETHEUS research programme.
    Parker A; Arundel C; Clark L; Coleman E; Doherty L; Hewitt CE; Beard D; Bower P; Cooper C; Culliford L; Devane D; Emsley R; Eldridge S; Galvin S; Gillies K; Montgomery A; Sutton CJ; Treweek S; Torgerson DJ
    Health Technol Assess; 2024 Jan; 28(2):1-114. PubMed ID: 38327177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial.
    Turner NC; Kingston B; Kilburn LS; Kernaghan S; Wardley AM; Macpherson IR; Baird RD; Roylance R; Stephens P; Oikonomidou O; Braybrooke JP; Tuthill M; Abraham J; Winter MC; Bye H; Hubank M; Gevensleben H; Cutts R; Snowdon C; Rea D; Cameron D; Shaaban A; Randle K; Martin S; Wilkinson K; Moretti L; Bliss JM; Ring A
    Lancet Oncol; 2020 Oct; 21(10):1296-1308. PubMed ID: 32919527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units.
    Love SB; Cafferty F; Snowdon C; Carty K; Savage J; Pallmann P; McParland L; Brown L; Masters L; Schiavone F; Hague D; Townsend S; Amos C; South A; Sturgeon K; Langley R; Maughan T; James N; Hall E; Kernaghan S; Bliss J; Turner N; Tutt A; Yap C; Firth C; Kong A; Mehanna H; Watts C; Hills R; Thomas I; Copland M; Bell S; Sebag-Montefiore D; Jones R; Parmar MKB; Sydes MR
    Trials; 2022 Sep; 23(1):757. PubMed ID: 36068599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experiences of running a stratified medicine adaptive platform trial: Challenges and lessons learned from 10 years of the FOCUS4 trial in metastatic colorectal cancer.
    Brown LC; Graham J; Fisher D; Adams R; Seligmann J; Seymour M; Kaplan R; Yates E; Parmar M; Richman SD; Quirke P; Butler R; Shiu K; Middleton G; Samuel L; Wilson RH; Maughan TS;
    Clin Trials; 2022 Apr; 19(2):146-157. PubMed ID: 35083924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols.
    Schiavone F; Bathia R; Letchemanan K; Masters L; Amos C; Bara A; Brown L; Gilson C; Pugh C; Atako N; Hudson F; Parmar M; Langley R; Kaplan RS; Parker C; Attard G; Clarke NW; Gillessen S; James ND; Maughan T; Sydes MR;
    Trials; 2019 May; 20(1):264. PubMed ID: 31138317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trial.
    Griffiths G; Fitzgerald R; Jaki T; Corkhill A; Marwood E; Reynolds H; Stanton L; Ewings S; Condie S; Wrixon E; Norton A; Radford M; Yeats S; Robertson J; Darby-Dowman R; Walker L; Khoo S;
    Trials; 2020 Jun; 21(1):544. PubMed ID: 32560744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A platform trial in practice: adding a new experimental research arm to the ongoing confirmatory FLAIR trial in chronic lymphocytic leukaemia.
    Howard DR; Hockaday A; Brown JM; Gregory WM; Todd S; Munir T; Oughton JB; Dimbleby C; Hillmen P
    Trials; 2021 Jan; 22(1):38. PubMed ID: 33419469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streamlined Operational Approaches and Use of e-Technologies in Clinical Trials: Beat Acute Myeloid Leukemia Master Trial.
    Rosenberg L; Levaux H; Levine RL; Shah A; Denmark J; Hereema N; Owen M; Kalk S; Kenny N; Vinson G; Vergilio JA; Mims A; Borate U; Blum W; Stein E; Gana TJ; Stefanos M; Yocum A; Marcus S; Shoben A; Druker B; Byrd J; Burd A
    Ther Innov Regul Sci; 2021 Sep; 55(5):926-935. PubMed ID: 33997942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical consideration when adding new arms to ongoing clinical trials: the potentials and the caveats.
    Lee KM; Brown LC; Jaki T; Stallard N; Wason J
    Trials; 2021 Mar; 22(1):203. PubMed ID: 33691748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer.
    Douglas JE; Liu S; Ma J; Wolff RA; Pant S; Maitra A; Tamm EP; Bhosale P; Katz MHG; Varadhachary GR; Koay EJ
    BMC Cancer; 2022 Jan; 22(1):14. PubMed ID: 34980020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing generic templates to shape the future for conducting integrated research platform trials.
    Gidh-Jain M; Parke T; König F; Spiertz C; Mesenbrink P;
    Trials; 2024 Mar; 25(1):204. PubMed ID: 38515103
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.